1TUB Stock Overview

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. More details

1TUB fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	2/6
Dividends	0/6

Risk Analysis

Earnings have declined by 30.9% per year over past 5 years

Makes less than USD$1m in revenue (€13K)

Volatile share price over the past 3 months compared to the Italian market

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Financière de Tubize SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Financière de Tubize
Historical stock prices
Current Share Price	€123.00
52 Week High	€0
52 Week Low	€0
Beta	0.42
1 Month Change	10.41%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-16.33%

Recent updates

Shareholder Returns

	1TUB	IT Pharmaceuticals	IT Market
7D	5.3%	-0.3%	0.6%
1Y	n/a	-19.1%	14.4%

Return vs Industry: Insufficient data to determine how 1TUB performed against the Italian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1TUB performed against the Italian Market.

Price Volatility

Is 1TUB's price volatile compared to industry and market?
1TUB volatility
1TUB Average Weekly Movement	8.0%
Pharmaceuticals Industry Average Movement	6.0%
Market Average Movement	5.4%
10% most volatile stocks in IT Market	8.8%
10% least volatile stocks in IT Market	3.5%

Stable Share Price: 1TUB's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1TUB's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1928	n/a	Eric Nys	www.financiere-tubize.be

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.

Financière de Tubize SA Fundamentals Summary

How do Financière de Tubize's earnings and revenue compare to its market cap?
1TUB fundamental statistics
Market cap	€5.59b
Earnings (TTM)	€90.10m
Revenue (TTM)	€13.26k

62.0x

P/E Ratio

Over9,999x

P/S Ratio

Is 1TUB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1TUB income statement (TTM)
Revenue	€13.26k
Cost of Revenue	€2.24m
Gross Profit	-€2.22m
Other Expenses	-€92.33m
Earnings	€90.10m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 02, 2025

Earnings per share (EPS)	2.02
Gross Margin	-16,767.63%
Net Profit Margin	679,673.60%
Debt/Equity Ratio	2.2%

How did 1TUB perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

51%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 12:09
End of Day Share Price	2025/05/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Financière de Tubize SA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Marc Debrouwer	Degroof Petercam

Financière de Tubize BIT:1TUB Stock Report